UCLA Study: Accelerated 5-Day Brain Stimulation Matches Efficacy of 6-Week Depression Treatment
UCLA researchers find that a 5-day accelerated TMS protocol is as effective as traditional 6-week depression treatments, offering a faster path to remission.
By: AXL Media
Published: Feb 25, 2026, 5:51 AM EST
Source: The information in this article was sourced from University of California - Los Angeles Health Sciences (February 25, 2026).

Breaking the Conventional Treatment Barrier Transcranial Magnetic Stimulation (TMS) has long been a lifeline for the 30–40% of depression patients who do not respond to standard antidepressants. However, the traditional requirement of daily clinic visits for up to eight weeks often serves as a logistical hurdle. The UCLA study published in the Journal of Affective Disorders highlights a pivotal shift, showing that 25 sessions condensed into a single workweek can trigger the same neurological recovery as the protracted version, potentially democratizing access to the therapy.
The "5x5" Protocol vs. Standard Care The research compared 135 patients on the standard six-week protocol with 40 patients undergoing the accelerated "5x5" format (five sessions daily for five days). Results indicated no statistically significant difference in the overall reduction of depressive symptoms between the two groups. Both cohorts saw substantial gains, reinforcing the theory that the brain’s mood-regulating circuits can be effectively "recalibrated" through high-density magnetic pulsing without needing months of incremental stimulation.
The Phenomenon of Delayed Improvement A critical finding for clinicians and patients alike was the "latent response" observed in the accelerated group. Many patients who showed minimal change immediately following the five-day burst experienced a dramatic drop in depression scores—averaging 36%—when evaluated two to four weeks later. This suggests that the biological "reset" triggered by TMS may take several weeks to fully manifest in a patient's daily mood and behavior, even if the active treatment phase is over.
Clinical Resilience in Treatment-Resistant Cases Every participant in the study had previously failed multiple medication trials, yet many achieved significant relief or even total remission through the 5x5 approach. Senior author Dr. Andrew Leuchter noted that for those who don't feel better by day five, the data provides a reason for optimism rather than discouragement. The research even hints that adding one or two "booster" days after a two-week gap could further amplify the antidepressant effects for slow responders.
Future Horizons: Beyond Major Depressive Disorder While this study focused on depression, the success of accelerated TMS has opened doors for wider applications. UCLA scientists are currently investigating the 5x...
Categories
Topics
Related Coverage
- Renowned Neuroscientist Dr. Mary Phillips Maps Bipolar Disorder Circuitry to Predict Symptoms Before They Surface
- New Zealand Researchers Target Global Market with Breakthrough Ketamine Tablet
- Global Psychiatry Reaches Milestone With Launch Of World’s Largest Integrated Dataset For Personalized Bipolar Disorder Treatment
- Japanese Researchers Identify NOX-1 Enzyme as Key to Extending Ketamine’s Rapid Antidepressant Effects